Sai Life Sciences Faces IGST Demand of Rs 16.28 Crore Over Alleged Excess ITC Claim
Sai Life Sciences Limited, a leading global Contract Research, Development, and Manufacturing Organisation, has recently issued a disclosure to NSE Ltd and BSE Ltd regarding receipt of a demand order.
Background
The company informed that the joint commissioner of commercial Taxes (Appeals) passed an order under section 107(11) of the Goods and Services Tax Act, 2017, with a demand of IGST amounting to Rs 16,28,46,397 along with interest and penalty.
Details of the violation
The Company has stated that the demand has been raised by the concerned authority, alleging excess availment of Input Tax Credit (ITC) in GSTR-3B over and above the amount reflected in GSTR-2A for FY 2021-22.
Key details
| Particulars | Details |
| Company | Sai Life Sciences Limited |
| Issuing Authority | Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi. |
| Tax Demand | Rs 16,28,46,397 |
| Interest | Rs 13,31,50,353 |
| Penalty | Rs 32,569,279 |
| Date of receipt | April 29, 2026 |
Company’s Further Step
The company said it will appeal the decision and hopes to get a positive result from the Tribunal.
Financial Impact
The company also believes that the order will not have any significant financial impact on the company.
Company’s Disclosure
The company made the above disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
